1. CD26/DPP4 - a potential biomarker and target for cancer therapy;Enz;Pharmacol Ther,2019
2. DPPIV/CD26: a tumor suppressor or a marker of malignancy?;Beckenkamp;Tumor Biol,2016
3. A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancers;Ali;Mol Clin Oncol,2019
4. A multi-center retrospective analysis examining the effect of dipeptidyl peptidase-4 inhibitors on progression-free survival in patients with prostate cancer;Pan;Cureus,2021
5. Shah C, Hong YR, Bishnoi R, et al. Impact of DPP4 inhibitors in survival of patients with prostate, pancreas, and breast cancer. Front Oncol. 2020;10:405. doi:10.3389/fonc.2020.00405